CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 41 enrolled
Drug / intervention
etafilcon A +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02328937
NCT02328937N/ACompleted
CompareCT.gov

Daily Wear Central Corneal Swelling With Etafilcon A and 2 Silicone Hydrogel Materials

Johnson & Johnson Vision Care, Inc.·interventional·Posted Dec 31, 2014·Updated Jun 19, 2018

In Brief

A clinical study evaluating etafilcon A, lotrafilcon B, and 1 other intervention for Corneal Swelling. Completed, enrolled 41 participants across 1 site.

Detailed Summary

This is a prospective, single site, unmasked, cross-over study with three silicone hydrogel contact lenses comparing central corneal swelling.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCorneal Swelling
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 31, 2014
Enrollment StartNov 1, 2014
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 11.5 years ago

Interventions

etafilcon Adevice

spherical hydrophilic soft contact lens worn in a daily wear modality

lotrafilcon Bdevice

comfilcon Adevice